Clinical Trials Directory

Trials / Conditions / Neoplasms, Prostate

Neoplasms, Prostate

19 registered clinical trials studyying Neoplasms, Prostate — 5 currently recruiting.

StatusTrialSponsorPhase
RecruitingFirst-Time-in-Human Study of GSK5471713 in Adults With mCRPC
NCT07332455
GlaxoSmithKlinePhase 1 / Phase 2
RecruitingInvestigation of Impact of AI on Prostate Cancer Workflow
NCT07084779
Case Comprehensive Cancer CenterN/A
RecruitingA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With
NCT06990880
GlaxoSmithKlinePhase 1 / Phase 2
RecruitingMRI/Ultrasound Fusion Guided Laser Ablation of Prostate Cancer
NCT05241236
Urological Research Network, LLC—
TerminatedP-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRP
NCT04249947
Poseida Therapeutics, Inc.Phase 1
TerminatedSafety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer
NCT02349139
Asana BioSciencesPhase 1
CompletedVaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical Prostatectomy
NCT02153918
National Cancer Institute (NCI)Phase 2
RecruitingMRI/Ultrasound Fusion Guided Prostate Cryotherapy
NCT02381990
Urological Research Network, LLC—
CompletedSipuleucel-T Manufacturing Demonstration Study
NCT01477749
DendreonPhase 2
CompletedKorean Practice Patterns for Screening PCA(Prostate Cancer)
NCT01371513
GlaxoSmithKline—
CompletedEconomic Analyses of the REDUCE Trial
NCT01337258
GlaxoSmithKline—
CompletedQuality of Life After Permanent Interstitial Iodine Seed Prostate Brachytherapy
NCT02652000
Kantonsspital Graubuenden—
CompletedDendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Abl
NCT00970203
Roswell Park Cancer InstitutePhase 2
CompletedARI103094-Follow-Up Study for REDUCE Study Subjects
NCT00883909
GlaxoSmithKline—
CompletedARTS - AVODART After Radical Therapy For Prostate Cancer Study
NCT00558363
GlaxoSmithKlinePhase 2
CompletedProstate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy
NCT00470834
GlaxoSmithKlinePhase 4
CompletedAssessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cance
NCT00363311
GlaxoSmithKlinePhase 4
CompletedSafety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate
NCT00148928
GlaxoSmithKlinePhase 1
Completed"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Ri
NCT00056407
GlaxoSmithKlinePhase 3